Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis
Although cranial radiotherapy is considered the standard treatment for brain metastasis (BM), EGFR tyrosine kinase inhibitors (TKIs) have shown promising activity in EGFR mutant non-small cell lung cancer (NSCLC) patients with BM. However, the efficacy of sequential cranial radiotherapy in patients...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer US
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958121/ |